KDR and Hypertension: Off-target effects occur due to a lack of kinase selectivity, leading to toxicity in normal tissues, such as hypertension caused by vascular endothelial growth factor receptor (VEGFR) inhibitors, limiting the therapeutic window of treatment [30,31].